Article Information
History
- December 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Satyen Sanghavi, Director1,
- Dr. Vinayak Kedage, Director of Research & Development1,*,
- Rajesh Pratap Singh, Assistant Director of Cell Therapy3,
- Parvathi Chandran, Senior Manager of Research Strategy & Communication3,
- Vidya Jadhav, Senior Manager of Cell Therapy3 and
- Sujata Shinde, Assistant Manager of Quality Control3
- 1Regrow Therapeutics Pvt. Ltd, 3 - ABC, ACME PLAZA, Andheri - Kurla Road, near Chakala, Andheri East, Mumbai, Maharashtra, India – 400059
- 3Regrow Biosciences Pvt. Ltd., 22 Shah Industrial Estate, Nangargaon, Lonavala, Maharashtra, India – 410401
- ↵*Corresponding author: Dr. Vinayak Kedage, Director of Research & Development, Regrow Therapeutics Pvt. Ltd, 3 - ABC, ACME PLAZA, Andheri - Kurla Road, near Chakala, Andheri East, Mumbai, Maharashtra, India - 400059. Email: drvinayak{at}regrowtx.in
Posted December 21, 2021.
Effect of Human Mesenchymal Stem Cells on Freund’s adjuvant-induced Rheumatoid Arthritis in Sprague Dawley Rats
